Published in Semin Reprod Med on April 08, 2014
Soy but not bisphenol A (BPA) induces hallmarks of polycystic ovary syndrome (PCOS) and related metabolic co-morbidities in rats. Reprod Toxicol (2014) 0.78
Effect of maternal PCOS and PCOS-like phenotype on the offspring's health. Mol Cell Endocrinol (2015) 0.78
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod (2004) 12.27
Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect (2008) 8.60
Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA (2008) 8.44
Human exposure to bisphenol A (BPA). Reprod Toxicol (2007) 6.91
Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev (2012) 6.12
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Exposure to bisphenol A advances puberty. Nature (1999) 4.54
Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology (2006) 4.22
Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ Health Perspect (2011) 4.15
In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol (2007) 3.69
Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect (2011) 3.56
Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod (2002) 3.45
Association between urinary bisphenol A concentration and obesity prevalence in children and adolescents. JAMA (2012) 3.34
Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect (2001) 3.00
In utero exposure to bisphenol A alters the development and tissue organization of the mouse mammary gland. Biol Reprod (2001) 2.96
Human exposure to bisphenol A. Toxicology (2006) 2.71
The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect (2006) 2.59
Human body burdens of chemicals used in plastic manufacture. Philos Trans R Soc Lond B Biol Sci (2009) 2.58
Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect (2008) 2.56
Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect (2010) 2.35
Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev (2012) 2.22
Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J (2004) 2.18
Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One (2010) 2.15
Prenatal exposure to bisphenol a at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Environ Health Perspect (2009) 2.11
Epigenetic transgenerational actions of endocrine disruptors. Endocrinology (2006) 2.08
Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update (2005) 2.07
Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol (2002) 2.05
Environmentally induced epigenetic transgenerational inheritance of ovarian disease. PLoS One (2012) 2.05
Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun (2002) 2.04
Urinary bisphenol A and obesity: NHANES 2003-2006. Environ Res (2011) 2.02
Exposure to environmentally relevant doses of the xenoestrogen bisphenol-A alters development of the fetal mouse mammary gland. Endocrinology (2006) 1.90
Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect (2013) 1.89
Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. PLoS One (2013) 1.88
Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res (2001) 1.82
Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One (2008) 1.81
Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res (1990) 1.75
Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol (2007) 1.70
It's not how fat you are, it's what you do with it that counts. PLoS Biol (2008) 1.69
Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci (2005) 1.66
Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance. J Clin Endocrinol Metab (2011) 1.63
The estrogenic endocrine disrupting chemical bisphenol A (BPA) and obesity. Mol Cell Endocrinol (2012) 1.53
The pancreatic beta-cell as a target of estrogens and xenoestrogens: Implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol (2009) 1.53
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update (2009) 1.52
Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity. Birth Defects Res C Embryo Today (2011) 1.52
Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J Biochem (2007) 1.51
Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation (2012) 1.48
In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia (2002) 1.48
Canned soup consumption and urinary bisphenol A: a randomized crossover trial. JAMA (2011) 1.47
Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril (2008) 1.44
The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG (2006) 1.44
Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev (2002) 1.43
Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun (2011) 1.43
Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab (2007) 1.35
Neurodevelopment and endocrine disruption. Environ Health Perspect (2004) 1.29
Dioxin (TCDD) induces epigenetic transgenerational inheritance of adult onset disease and sperm epimutations. PLoS One (2012) 1.28
Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl (2007) 1.28
Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS. J Clin Endocrinol Metab (2010) 1.24
Hydrocarbons (jet fuel JP-8) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations. Reprod Toxicol (2013) 1.23
Low dose mixture effects of endocrine disrupters: implications for risk assessment and epidemiology. Int J Androl (2008) 1.21
Neonatal exposure to bisphenol a alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Environ Health Perspect (2009) 1.21
Effect of bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrinol (2007) 1.20
Neonatal bisphenol-a exposure alters rat reproductive development and ovarian morphology without impairing activation of gonadotropin-releasing hormone neurons. Biol Reprod (2009) 1.19
Unravelling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) (2007) 1.18
Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab (1996) 1.18
Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk? Neurotoxicology (2005) 1.18
Glucuronidation of the environmental oestrogen bisphenol A by an isoform of UDP-glucuronosyltransferase, UGT2B1, in the rat liver. Biochem J (1999) 1.17
Neonatal exposure to bisphenol a and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect (2010) 1.14
Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology (1997) 1.14
Dietary xenoestrogens differentially impair 3T3-L1 preadipocyte differentiation and persistently affect leptin synthesis. J Steroid Biochem Mol Biol (2008) 1.13
The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev (2012) 1.10
Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyltransferase activity. Endocr J (2006) 1.09
Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril (1990) 1.09
Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional study. Environ Health (2012) 1.07
Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol (2012) 1.07
The role of genes and environment in the etiology of PCOS. Endocrine (2006) 1.05
Urine bisphenol-A level in relation to obesity and overweight in school-age children. PLoS One (2013) 1.05
The environmental obesogen bisphenol A promotes adipogenesis by increasing the amount of 11β-hydroxysteroid dehydrogenase type 1 in the adipose tissue of children. Int J Obes (Lond) (2012) 1.04
Effects of endocrine disrupting chemicals on in vitro global DNA methylation and adipocyte differentiation. Toxicol In Vitro (2013) 1.02
Urinary bisphenol A and hypertension in a multiethnic sample of US adults. J Environ Public Health (2012) 1.01
Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol (2013) 1.01
Epigenetic modification of the X chromosome influences susceptibility to polycystic ovary syndrome. J Clin Endocrinol Metab (2006) 1.01
Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids (1999) 1.00
Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype. Hum Reprod (2009) 0.99
Changes in reproductive organs of female rats treated with bisphenol A during the neonatal period. Reprod Toxicol (2003) 0.99
Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect (2012) 0.99
Short-term treatment with bisphenol-A leads to metabolic abnormalities in adult male mice. PLoS One (2012) 0.98
Adipose tissue expandability and the early origins of PCOS. Trends Endocrinol Metab (2009) 0.98
Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis. Clin Endocrinol (Oxf) (2013) 0.98
Androgen receptor CAG repeat polymorphism and epigenetic influence among the south Indian women with Polycystic Ovary Syndrome. PLoS One (2010) 0.96
Gender difference in serum bisphenol A levels may be caused by liver UDP-glucuronosyltransferase activity in rats. Biochem Biophys Res Commun (2004) 0.96
Obesity and PCOS: implications for diagnosis and treatment. Semin Reprod Med (2012) 0.94
Epigenetic abnormality: a possible mechanism underlying the fetal origin of polycystic ovary syndrome. Med Hypotheses (2007) 0.94
Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver. Arch Toxicol (1998) 0.94
Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertil Steril (2012) 0.93
Developmental effects of prenatal exposure to bisphenol a on the uterus of rat offspring. Neoplasia (2004) 0.90
Bridging epidemiology and model organisms to increase understanding of endocrine disrupting chemicals and human health effects. J Steroid Biochem Mol Biol (2010) 0.89
Genetic approaches to polycystic ovarian syndrome. Curr Opin Obstet Gynecol (2007) 0.89
Effect of environmental contaminants on Beta cell function. Int J Toxicol (2011) 0.88
Evidence of subpopulations with different levels of insulin resistance in women with polycystic ovary syndrome. Hum Reprod (2007) 0.86
Phenotypes and enviromental factors: their influence in PCOS. Curr Pharm Des (2012) 0.86